Serum pigment epithelium-derived factor levels are independently correlated with the presence of coronary artery disease

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Wang, Feifei ^a   Ma, Xiaojing ^a   Zhou, Mi ^a   Pan, Xiaoping ^a   Ni, Jie ^a   Gao, Meifang ^a   Lu, Zhigang ^a   Hang, Jingyu ^a   Bao, Yuqian ^a   Jia, Weiping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Atherosclerosis; Coronary angiography; Coronary artery disease; Metabolic syndrome; Pigment epithelium derived factor

Indexed keywords

C REACTIVE PROTEIN; PIGMENT EPITHELIUM DERIVED FACTOR; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; ENZYME IMMUNOASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; EYE PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; RISK FACTORS; SERPINS;

EID: 84875501389     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-56     Document Type: Article

References (38)

1. Tombran-Tink J, Johnson LV. Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest Ophthalmol Vis Sci 1989, 30:1700-1707.
2. Tombran-Tink J, Mazuruk K, Rodriguez IR, Chung D, Linker T, Englander E, Chader GJ. Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Mol Vis 1996, 2:11.
3. Wang P, Mariman E, Keijer J, Bouwman F, Noben JP, Robben J, Renes J. Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines. Cell Mol Life Sci 2004, 61:2405-2417.
4. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999, 285:245-248. 10.1126/science.285.5425.245, 10398599.
5. Bouck N. PEDF: anti-angiogenic guardian of ocular function. Trends Mol Med 2002, 8:330-334. 10.1016/S1471-4914(02)02362-6, 12114112.
6. Volpert OV, Zaichuk T, Zhou W, Reiher F, Ferguson TA, Stuart PM, Amin M, Bouck NP. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment-derived factor. Nat Med 2002, 8:349-357. 10.1038/nm0402-349, 11927940.
7. Nakamura K, Yamagishi S, Matsui T, Yoshida T, Takenaka K, Jinnouchi Y, Yoshida Y, Ueda S, Adachi H, Imaizumi T. Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation. Am J Pathol 2007, 170:2159-2170. 10.2353/ajpath.2007.060838, 1899461, 17525281.
8. Takenaka K, Yamagishi S, Matsui T, Nakamura K, Jinnouchi Y, Yoshida Y, Ueda S, Katsuki Y, Katsuda Y, Imaizumi T. Pigment epithelium-derived factor (PEDF) administration inhibits occlusive thrombus formation in rats: a possible participation of reduced intraplatelet PEDF in thrombosis of acute coronary syndromes. Atherosclerosis 2008, 197:25-33. 10.1016/j.atherosclerosis.2007.07.041, 17850801.
9. Zamiri P, Masli S, Streilein JW, Taylor AW. Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation. Invest Ophthalmol Vis Sci 2006, 47:3912-3918. 10.1167/iovs.05-1267, 16936104.
10. Yamagishi S, Kikuchi S, Nakamura K, Matsui T, Takeuchi M, Inoue H. Pigment epithelium-derived factor (PEDF) blocks angiotensin II induced T cell proliferation by suppressing autocrine production of interleukin-2. Med Chem 2006, 2:265-269. 10.2174/157340606776930826, 16948472.
11. Zhang SX, Wang JJ, Gao G, Shao C, Mott R, Ma JX. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor. FASEB J 2006, 20:323-325.
12. Yamagishi S, Adachi H, Abe A, Yashiro T, Enomoto M, Furuki K, Hino A, Jinnouchi Y, Takenaka K, Matsui T, Nakamura K, Imaizumi T. Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. J Clin Endocrinol Metab 2006, 91:2447-2450. 10.1210/jc.2005-2654, 16522692.
13. Chen C, Tso AW, Law LS, Cheung BM, Ong KL, Wat NM, Janus ED, Xu A, Lam KS. Plasma level of pigment epithelium-derived factor is independently associated with the development of the metabolic syndrome in Chinese men: a 10-year prospective study. J Clin Endocrinol Metab 2010, 95:5074-5081. 10.1210/jc.2010-0727, 20685859.
14. Stejskal D, Karpísek M, Svesták M, Hejduk P, Sporová L, Kotolová H. Pigment epithelium-derived factor as a new marker of metabolic syndrome in Caucasian population. J Clin Lab Anal 2010, 24:17-19. 10.1002/jcla.20360, 20087951.
15. Tahara N, Yamagishi S, Tahara A, Nitta Y, Kodama N, Mizoguchi M, Mohar D, Ishibashi M, Hayabuchi N, Imaizumi T. Serum level of pigment epithelium-derived factor is a marker of atherosclerosis in humans. Atherosclerosis 2011, 219:311-315. 10.1016/j.atherosclerosis.2011.06.022, 21733518.
16. Yamagishi S, Matsui T, Nakamura K. Atheroprotective properties of pigment epithelium-derived factor (PEDF) in cardiometabolic disorders. Curr Pharm Des 2009, 15:1027-1033. 10.2174/138161209787581940, 19275665.
17. Rychli K, Huber K, Wojta J. Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease. Expert Opin Ther Targets 2009, 13:1295-1302. 10.1517/14728220903241641, 19694500.
18. Yang G, Fan L, Tan J, Qi G, Zhang Y, Samet JM, Taylor CE, Becker K, Xu J. Smoking in China: findings of the 1996 NAtional Prevalence Survey. JAMA 1999, 282:1247-1253. 10.1001/jama.282.13.1247, 10517427.
19. Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi 2007, 35:390-419. Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults.
20. Judkins MP. Percutaneous transfemoral selective coronary arteriography. Radiol Clin North Am 1968, 6:467-492.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419. 10.1007/BF00280883, 3899825.
22. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999, 130:461-470.
23. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F, American Heart Association Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation 2005, 112:2735-2752. 10.1161/CIRCULATIONAHA.105.169404, 16157765, American Heart Association.
24. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007, 49:403-414. 10.1016/j.jacc.2006.09.032, 17258085.
25. Assmann G, Schulte H, von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 1996, 77:1179-1184. 10.1016/S0002-9149(96)00159-2, 8651092.
26. Sone H, Tanaka S, Iimuro S, Oida K, Yamasaki Y, Oikawa S, Ishibashi S, Katayama S, Ohashi Y, Akanuma Y, Yamada N, Japan Diabetes Complications Study Group Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS). J Clin Endocrinol Metab 2011, 96:3448-3456. 10.1210/jc.2011-0622, 21865372, Japan Diabetes Complications Study Group.
27. Borg ML, Andrews ZB, Duh EJ, Zechner R, Meikle PJ, Watt MJ. Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase. Diabetes 2011, 60:1458-1466. 10.2337/db10-0845, 3292318, 21464445.
28. Chader GJ. Surmountable challenges in translating pigment epithelium-derived factor (PEDF) therapy from animal models to clinical trials for retinal degenerations. Retina 2005, 25:S29-S30. 10.1097/00006982-200512001-00011, 16374323.
29. Chen HB, Jia WP, Lu JX, Bao YQ, Li Q, Lu FD, Lu W, Yu HY, Xiang KS. Change and significance of serum pigment epithelium-derived factor in type 2 diabetic nephropathy. Zhonghua Yi Xue Za Zhi 2007, 87:1230-1233.
30. Yamagishi S, Matsui T, Nakamura K, Ueda S, Noda Y, Imaizumi T. Pigment epithelium-derived factor (PEDF): its potential therapeutic implication in diabetic vascular complications. Curr Drug Targets 2008, 9:1025-1029. 10.2174/138945008786786154, 18991613.
31. Shiga Y, Miura S, Mitsutake R, Yamagishi S, Saku K. Significance of plasma levels of pigment epithelium-derived factor as determined by multidetector row computed tomography in patients with mild chronic kidney disease and/or coronary artery disease. J Int Med Res 2011, 39:880-890. 10.1177/147323001103900322, 21819721.
32. Epstein FH, Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126. 10.1056/NEJM199901143400207, 9887164.
33. Umei H, Yamagishi SI, Imaizumi T. Positive association of serum levels of pigment epithelium-derived factor with high-sensitivity C-reactive protein in apparently healthy unmedicated subjects. J Int Med Res 2010, 38:443-448. 10.1177/147323001003800207, 20515558.
34. Nakamura K, Yamagishi S, Yoshida T, Matsui T, Imaizumi T, Inoue H, Sata M. Hydrogen peroxide stimulates pigment epithelium-derived factor gene and protein expression in the human hepatocyte cell line OUMS-29. J Int Med Res 2007, 35:427-432. 10.1177/147323000703500319, 17593873.
35. Ueda S, Yamagishi S, Matsui T, Jinnouchi Y, Imaizumi T. Administration of pigment-derived factor inhibits left ventricular remodeling and improves cardiac function in rats with acute myocardial infarction. Am J Pathol 2011, 178:591-598. 10.1016/j.ajpath.2010.10.018, 3278887, 21281791.
36. Rychli K, Niessner A, Hohensinner PJ, Mahdy Ali K, Kaun C, Neuhold S, Zorn G, Richter B, Hülsmann M, Berger R, Mörtl D, Huber K, Maurer G, Pacher R, Wojta J. Prognostic value of pigment epithelium-derived factor in patients with advanced heart failure. Chest 2010, 138:656-664. 10.1378/chest.09-2739, 20435653.
37. Chong ZZ, Maiese K. Mammalian target of rapamycin signaling in diabetic cardiovascular disease. Cardiovasc Diabetol 2012, 11:45. 10.1186/1475-2840-11-45, 3398846, 22545721.
38. Wang B, Atherton P, Patel R, Manning G, Donnelly R. Antiangiogenic effects and transcriptional regulation of pigment epithelium-derived factor in diabetic retinopathy. Microvasc Res 2010, 80:31-36. 10.1016/j.mvr.2010.02.012, 20219495.